This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: András Aszódi: Therapeutic Antibody Innovation
Introduction
András Aszódi is an inventor associated with Novartis AG in Vienna, Austria. His patent work includes a therapeutic binding molecule designed for potential pharmaceutical use.
Latest Patents
The supplied information identifies one patent for Aszódi: “Therapeutic binding molecules.” It describes a molecule with an antigen-binding site containing specified CDR1, CDR2, and CDR3 amino acid sequences. The disclosure also describes an example with a second set of hypervariable regions and notes that the molecule may be a chimeric or humanized antibody. The invention is presented as useful as a pharmaceutical. The supplied data does not establish the patent’s filing date or whether it is the latest patent.
Career Highlights
Aszódi’s listed patent reflects work on antibody-based therapeutic molecules and their antigen-binding regions. The supplied information associates him with Novartis AG and records 1 patent.
Collaborations
The listed coworkers are Gregorio Aversa and Bruce Milne Hall. The supplied information does not specify the nature of their collaboration with Aszódi.
Conclusion
András Aszódi’s recorded patent contribution concerns therapeutic binding molecules, including antibody designs with defined antigen-binding regions and potential pharmaceutical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
